Blended Learning in Future Physiotherapy Professionals

April 18, 2023 updated by: David Hernández-Guillén, University of Valencia

Effectiveness of a Heart Disease Blended Learning Program in Future Physiotherapy Professionals: A Prospective Study

Blended Learning (BL) is proving to be an effective method of teaching within the health professions . However, there are still scarce studies on BL conducted with undergraduate physiotherapy students. Therefore, the aim of this study was to determine the effectiveness of a heart disease BL programme in knowledge, motivation, engagement, design of the programme instructions and learning behaviours in physiotherapy students.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

124

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Valencia, Spain, 46010
        • University of Valencia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • studying a Physiotherapy Degree at the aforementioned University
  • to be willing to participate

Exclusion Criteria:

  • none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Physiotherapy students
The participants performed an 8-week heart disease blended learning program.
The intervention included face-to-face classes and online resources (Moodle, online syllabus, videos, websites, podcasts, activities, apps, forums, emails, tutoring).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Coronary Artery Disease Education Questionnaire (CADEQ)
Time Frame: 0 weeks
CADEQ includes 20 closed-ended questions about medical conditions, risk factors, exercise, nutrition, and psychosocial wellbeing with a single-word answer (yes, no). Total score ranges from 0 to 20 (0=poorest knowledge, 20=best knowledge).
0 weeks
Coronary Artery Disease Education Questionnaire (CADEQ)
Time Frame: 4 weeks
CADEQ includes 20 closed-ended questions about medical conditions, risk factors, exercise, nutrition, and psychosocial wellbeing with a single-word answer (yes, no). Total score ranges from 0 to 20 (0=poorest knowledge, 20=best knowledge).
4 weeks
Coronary Artery Disease Education Questionnaire (CADEQ)
Time Frame: 8 weeks
CADEQ includes 20 closed-ended questions about medical conditions, risk factors, exercise, nutrition, and psychosocial wellbeing with a single-word answer (yes, no). Total score ranges from 0 to 20 (0=poorest knowledge, 20=best knowledge).
8 weeks
Coronary Artery Disease Education Questionnaire (CADEQ)
Time Frame: 12 weeks
CADEQ includes 20 closed-ended questions about medical conditions, risk factors, exercise, nutrition, and psychosocial wellbeing with a single-word answer (yes, no). Total score ranges from 0 to 20 (0=poorest knowledge, 20=best knowledge).
12 weeks
Coronary Artery Disease Education Questionnaire (CADEQ)
Time Frame: 20 weeks
CADEQ includes 20 closed-ended questions about medical conditions, risk factors, exercise, nutrition, and psychosocial wellbeing with a single-word answer (yes, no). Total score ranges from 0 to 20 (0=poorest knowledge, 20=best knowledge).
20 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of the Dader Method in Cardiovascular Risk of Patients with Risk Factors or Cardiovascular Disease Questionnaire (EMDADER)
Time Frame: 0, 4, 8, 12 and 20 weeks
EMDADER is composed of 10 multiple-choice questions with four answer options on coronary artery disease and risk factors, and two questions to report weight and height. Total score ranges from 0 to 10 (0=poorest knowledge, 10=best knowledge).
0, 4, 8, 12 and 20 weeks
Academic Motivation Scale and Attributional Styles Questionnaire
Time Frame: 4, 8 weeks
The tool is composed of 24 items, using a 7-point Likert scale: from 1 (totally disagree) to 7 (totally agree). The scale integrates three domains related to learning motivation: Intrinsic Motivation (9 items), Performance Motivation (7 items) and Extrinsic Motivation (7 items). The maximum score is 7. The scale is prepared to add the different items even if they measure different items. They will not be interpreted separately.
4, 8 weeks
Student Engagement Questionnaire
Time Frame: 4, 8 weeks
It is a 35-item questionnaire, scored on a five-point Likert scale (1=totally disagree, 5=totally agree). The questionnaire is divided into five dimensions: Intellectual Capabilities (items 1-10), Working Together (items 11-16), Teaching (items 17-25), Teacher-student Relationship (items 26-29), and Student-student Relationship (items 30-35). The maximum score of the questionnaire is 5. The scale is prepared to add the different items even if they measure different items. They will not be interpreted separately.
4, 8 weeks
Community of Inquiry Survey
Time Frame: 0, 4, 8, 12 and 20 weeks
A 34-item questionnaire, scored on a five-point Likert scale (1=strongly disagree, 5=strongly agree) that includes three dimensions: i) Cognitive Presence (items 1-13), related to the degree to which participants are able to construct meaning and knowledge through continuous communication, reflection, and discussion; ii) Social Presence (items 14-22), related to the ability of participants to identify with the community, communicating and developing interpersonal relationships; iii) Teaching Presence (items 23-34), referring to the design, guidance and direction, on the part of teachers, of cognitive and social processes with the purpose of achieving the result of meaningful learning in students. The maximum score of the questionnaire is 5. The scale is prepared to add the different items even if they measure different items. They will not be interpreted separately.
0, 4, 8, 12 and 20 weeks
Learning behaviours (I)
Time Frame: 0, 4, 8, 12 and 20 weeks
Number of downloads were retrieved and collected from the institution's Moodle platform Virtual ClassroomTM, through class progress
0, 4, 8, 12 and 20 weeks
Learning behaviours (II)
Time Frame: 0, 4, 8, 12 and 20 weeks
Number of topics visited were retrieved and collected from the institution's Moodle platform Virtual ClassroomTM, through class progress
0, 4, 8, 12 and 20 weeks
Learning behaviours (III)
Time Frame: 0, 4, 8, 12 and 20 weeks
The score of questionnaires were retrieved and collected from the institution's Moodle platform Virtual ClassroomTM, through class progress
0, 4, 8, 12 and 20 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: David Hernández-Guillén, PT, PhD, University of Valencia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2021

Primary Completion (Actual)

February 28, 2021

Study Completion (Actual)

June 30, 2021

Study Registration Dates

First Submitted

November 25, 2022

First Submitted That Met QC Criteria

December 7, 2022

First Posted (Actual)

December 9, 2022

Study Record Updates

Last Update Posted (Actual)

April 19, 2023

Last Update Submitted That Met QC Criteria

April 18, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BL_HEART_01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Diseases

Clinical Trials on Blended learning in heart disease

Subscribe